CD4 and atherosclerosis: Additionally, proinflammatory CD4+ CD28null T cells and dysfunctional TREM2- SPP1+ foamy macrophages, which were associated with atherosclerosis progression and poor prognosis, were expected to be potential therapeutic targets for future precision medicine.